One of the most clinically relevant combinations for Direct Meds patients is DSIP alongside a GLP-1 agonist such as Semaglutide or Tirzepatide.
Why this combination works
GLP-1 medications can sometimes cause sleep disturbances or nighttime restlessness in new patients - a common side effect during the early weeks of treatment as the body adjusts. DSIP's ability to stabilize the HPA axis and lower cortisol can help mitigate this "sympathetic overdrive," making the GLP-1 adjustment period more manageable.
The downstream benefit
Better sleep quality is directly correlated with improved metabolic function and weight loss outcomes. Sleep deprivation is known to increase ghrelin (the hunger hormone) and reduce leptin (the satiety hormone), working against the goals of GLP-1 therapy. By supporting restorative sleep, DSIP helps patients get more from their weight management protocol - improved adherence, better recovery, and more consistent results.
If you are currently on a GLP-1 program and are interested in adding DSIP, bring this up with your care team. They will review your current protocol and health history to determine whether adding DSIP is appropriate and how to structure both therapies together.
Contact your care team through the patient portal or call 888-696-7176.